Pfizer plans to file for full FDA approval of Covid vaccine at the end of this month

by CNBC • New

In its earnings report, Pfizer reported $3.5 billion in first-quarter sales of its Covid-19 vaccine.

Read More on CNBC

Keep exploring with these related links:

Discover Stocks with SpeculatingStocks

Join the Social Network for Investors

Social & Financial Data on Stocks

Stock Comparison Tool

Stock Picks

Discuss Any Cryptocurrency

'Buy' Sentiment Data for Symbols

'Sell' Sentiment Data for Symbols